Yang SY - Search Results

1

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.

Fang Z, Song YX, Wo GQ, Zhou HL, Li L, Yang SY, Chen X, Zhang J, Tang JH. Fang Z, et al. Among authors: yang sy. Ann Transl Med. 2022 Dec;10(23):1280. doi: 10.21037/atm-22-5444. Ann Transl Med. 2022. PMID: 36618780 Free PMC article.

2

PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer.

Fang Z, Shen HY, Xu Q, Zhou HL, Li L, Yang SY, Zhu Z, Tang JH. Fang Z, et al. Among authors: yang sy. Front Oncol. 2022 Nov 15;12:1030571. doi: 10.3389/fonc.2022.1030571. eCollection 2022. Front Oncol. 2022. PMID: 36457503 Free PMC article.

3

CBX3 promotes breast cancer progression and high level of CBX3 predicts poor prognosis in patients.

Yang K, Wang YL, Zhu Z, Cao XH, Liang MX, Xu D, Fei YJ, Yang SY, Zhou HL, Tang JH. Yang K, et al. Among authors: yang sy. Neoplasma. 2023 Feb;70(1):71-81. doi: 10.4149/neo_2022_220622N656. Epub 2023 Jan 9. Neoplasma. 2023. PMID: 36620876

4

B7-H6 is a new potential biomarker and therapeutic target of T-lymphoblastic lymphoma.

Yuan L, Sun L, Yang S, Chen X, Wang J, Jing H, Zhao Y, Ke X. Yuan L, et al. Ann Transl Med. 2021 Feb;9(4):328. doi: 10.21037/atm-20-5308. Ann Transl Med. 2021. PMID: 33708955 Free PMC article.

5

Intratumoral heterogeneity contributes to the chemotherapy prognosis of breast cancer.

Li Y, Wang M, Yang S, Kuang L, Tao X, Yang J, Zhao W, Zhang J. Li Y, et al. J Cancer Res Ther. 2022 Sep;18(5):1268-1275. doi: 10.4103/jcrt.jcrt_1166_21. J Cancer Res Ther. 2022. PMID: 36204872 Free article.

6

High ETS2 expression predicts poor prognosis in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.

Zhang G, Zhang L, Yang X, Zhang X, Zhang J, Yang S, Wang J, Hu K, Shi J, Ke X, Fu L. Zhang G, et al. Ann Hematol. 2019 Feb;98(2):519-525. doi: 10.1007/s00277-018-3440-4. Epub 2018 Jul 18. Ann Hematol. 2019. PMID: 30022221 Clinical Trial. No abstract available.

7

Epigenetically altered miR‑193a‑3p promotes HER2 positive breast cancer aggressiveness by targeting GRB7.

Tang Y, Yang S, Wang M, Liu D, Liu Y, Zhang Y, Zhang Q. Tang Y, et al. Int J Mol Med. 2019 Jun;43(6):2352-2360. doi: 10.3892/ijmm.2019.4167. Epub 2019 Apr 15. Int J Mol Med. 2019. PMID: 31017268 Free PMC article.

8

Circular RNA hsa_circ_0001982 Promotes Breast Cancer Cell Carcinogenesis Through Decreasing miR-143.

Tang YY, Zhao P, Zou TN, Duan JJ, Zhi R, Yang SY, Yang DC, Wang XL. Tang YY, et al. Among authors: yang sy, yang dc. DNA Cell Biol. 2017 Nov;36(11):901-908. doi: 10.1089/dna.2017.3862. Epub 2017 Sep 21. DNA Cell Biol. 2017. PMID: 28933584

9

BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.

Zhang J, Shi J, Zhang G, Zhang X, Yang X, Yang S, Wang J, Ke X, Fu L. Zhang J, et al. Ann Hematol. 2018 Aug;97(8):1391-1397. doi: 10.1007/s00277-018-3331-8. Epub 2018 Apr 25. Ann Hematol. 2018. PMID: 29696374

10

High expression levels of SMAD3 and SMAD7 at diagnosis predict poor prognosis in acute myeloid leukemia patients undergoing chemotherapy.

Zhang J, Zhang L, Cui H, Zhang X, Zhang G, Yang X, Yang S, Zhang Z, Wang J, Hu K, Shi J, Ke X, Fu L. Zhang J, et al. Cancer Gene Ther. 2019 May;26(5-6):119-127. doi: 10.1038/s41417-018-0044-z. Epub 2018 Sep 4. Cancer Gene Ther. 2019. PMID: 30177817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,486 results

Search Page

Filters